- Home
- OSTX vs SACH Comparison
OSTX vs SACH Comparison
Compare OSTX & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSTX
- SACH
- Stock Information
- Founded
- OSTX 2018
- SACH 2010
- Country
- OSTX United States
- SACH United States
- Employees
- OSTX N/A
- SACH N/A
- Industry
- OSTX
- SACH Real Estate Investment Trusts
- Sector
- OSTX
- SACH Real Estate
- Exchange
- OSTX NYSE
- SACH Nasdaq
- Market Cap
- OSTX 43.0M
- SACH 46.7M
- IPO Year
- OSTX 2024
- SACH 2017
- Fundamental
- Price
- OSTX $1.83
- SACH $1.23
- Analyst Decision
- OSTX Strong Buy
- SACH Hold
- Analyst Count
- OSTX 3
- SACH 3
- Target Price
- OSTX $18.00
- SACH $2.25
- AVG Volume (30 Days)
- OSTX 756.1K
- SACH 243.2K
- Earning Date
- OSTX 08-14-2025
- SACH 08-13-2025
- Dividend Yield
- OSTX N/A
- SACH 16.26%
- EPS Growth
- OSTX N/A
- SACH N/A
- EPS
- OSTX N/A
- SACH N/A
- Revenue
- OSTX N/A
- SACH N/A
- Revenue This Year
- OSTX N/A
- SACH N/A
- Revenue Next Year
- OSTX N/A
- SACH $4.52
- P/E Ratio
- OSTX N/A
- SACH N/A
- Revenue Growth
- OSTX N/A
- SACH N/A
- 52 Week Low
- OSTX $1.12
- SACH $0.80
- 52 Week High
- OSTX $7.00
- SACH $3.07
- Technical
- Relative Strength Index (RSI)
- OSTX N/A
- SACH 62.47
- Support Level
- OSTX N/A
- SACH $1.14
- Resistance Level
- OSTX N/A
- SACH $1.23
- Average True Range (ATR)
- OSTX 0.00
- SACH 0.06
- MACD
- OSTX 0.00
- SACH 0.01
- Stochastic Oscillator
- OSTX 0.00
- SACH 90.91
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments in cancers of the bone in children and young adults.
About SACH Sachem Capital Corp.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.